Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial. - Concepedia

Concepedia

Publication | Closed Access

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.

23

Citations

23

References

1995

Year

C.-H. Köhne, Wolfgang Hiddemann, J. Schüller, Joseph B. Weiss, H. -P. Lohrmann, U Schmitz-Hübner, H Bodenstein, C. Schöber, Hans‐Joachim Wilke, Jean L. Grem

Journal of Clinical Oncology

Abstract

Orally administered DP did not improve the antineoplastic activity of 5-FU/FA in patients with advanced colorectal cancer when used at this dose and schedule. The observed increase in 5-FU dose-intensity for FU/FA/DP was not clinically relevant.

References

	Year	Citations

Page 1